Provided by Tiger Trade Technology Pte. Ltd.

Sinovac Biotech

6.47
0.0000
Volume:- -
Turnover:- -
Market Cap:464.94M
PE:-7.80
High:6.47
Open:6.47
Low:6.47
Close:6.47
52wk High:6.47
52wk Low:6.47
Shares:71.86M
Float Shares:31.17M
Volume Ratio:0.52
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8300
EPS(LYR):1.06
ROE:25.15%
ROA:11.46%
PB:0.62
PE(LYR):6.13

Loading ...

Sinovac Reports Nasdaq Delist Notice Over Late Annual Report Filing

MT Newswires Live
·
May 30

Sinovac Biotech receives Nasdaq notification regarding late report filing

TIPRANKS
·
May 30

BRIEF-SINOVAC Receives Nasdaq Notification Regarding Late Filing Of 2025 Annual Report

Reuters
·
May 30

Sinovac faces Nasdaq delisting risk after missing 2025 annual report filing deadline

Reuters
·
May 30

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report

THOMSON REUTERS
·
May 30

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:34 AM

Reuters
·
May 29

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 11:48 AM

Reuters
·
May 27

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:00 AM

Reuters
·
May 26

Is CrowdStrike (CRWD) Using Its SVA Deal To Deepen Europe Ties Or Just Expand Distribution?

Simply Wall St.
·
May 23

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:50 AM

Reuters
·
May 22

Sinovac Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

THOMSON REUTERS
·
May 21

Sinovac Biotech Ltd - Extends Submission Deadline for Payment Instructions to June 30, 2026

THOMSON REUTERS
·
May 21

Press Release: SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Dow Jones
·
May 21

CrowdStrike, SVA Partner for Cybersecurity Services in Germany

MT Newswires Live
·
May 20

Newtrend appoints Zhang Qian as independent non-executive director

Reuters
·
May 14

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM

Reuters
·
May 10

Sinovac Biotech Reports Nearly 30% Surge in First-Half Overseas Revenue, Mitigating Domestic Market Decline

Deep News
·
May 09

Sinovac Biotech H1 Adj. EPS $0.06 Down From $1.18 YoY, Sales $130.270M Up From $128.711M YoY

Benzinga Earnings
·
May 09

Sinovac FY25 H1 swings to net loss of $21.7 million; net sales rise 1.21% to $130.3 million

Reuters
·
May 09

Sinovac Reports Unaudited First Half of 2025 Financial Results

THOMSON REUTERS
·
May 09